Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study

xlomafota13 shared this article with you from Inoreader Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study Via Acta Otorrinolaringológica Española Publication date: Available online 18 June 2021 Source: Acta Otorrinolaringológica Española Author(s): Yuria Ablanedo-Terrazas, Oscar Estrada-Camacho, Claudia Alvarado-de la Barrera, Arturo Ramírez-García, Gabriel Tona-Acedo, Daniel Bross-Soriano, José Schimelmitz-Idi View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.